
Nanobiotix appoints head from Roche
pharmafile | April 22, 2014 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Roche, nanobiotix, otin
France-based clinical-stage nanomedicine firm Nanobiotix has hired Thierry Otin as its head of manufacturing and supply.
Prior to joining Nanobiotix, Otin was the quality site manager (EU Sterile) at Roche and before then, he worked at LFB Biotechnologies as the head pharmacist (pharmaceutical qualified person) and quality director.
Prior to this, he worked in QA/GMP and manufacturing with companies including: Schering CISBiointernational, Institut de Formation des Industries de Santé (IFIS), UCB, Delagrange and Rhône-Poulenc (Roger Bellon and Specia).
Laurent Levy, chief executive of Nanobiotix says: “Thierry Otin joins us having had over 30 years’ experience in the global pharmaceutical industry which includes 12+ years’ experience of injectable drug production management and 11+ years in QA senior compliance management. This wealth of expertise will be invaluable to us as we move our lead product to commercialisation. We welcome him to the team.”
Related Content

Roche receives CE Mark for blood test to help rule out Alzheimer’s
Roche has been granted CE Mark approval for its Elecsys pTau181 test, the first in …

Roche candidate shows early promise for treating haemophilia A
Roche has announced encouraging early results from its phase 1/2 trial of NXT007, an investigational …

Roche advances treatment for Parkinson’s disease
Swiss biopharma, Roche, has announced its decision to proceed with phase 3 trials of prasinezumab, …






